Page 11 - Biological E News Today

Biological E has sought permission from India's drug regulator to conduct the phase-3 clinical trial for its COVID-19 vaccine Corbevax as a single booster dose for those who have been fully vaccinated with Covishield or Covaxin.

The southern hemisphere is not vaccinated? and to that i say, look, the mrna vaccines were never intended to vaccinate the world with a brand-new technology you just cannot make enough of it and thats why where our vaccine comes in, a low cost similar levels of protection, easily accessible vaccine that theres no limit to the amount you can scale and so weve been frustrated not having more help from the u.s. government and the international bodies on our own, weve been scaling up production with...

Union Health Minister Mansukh Mandaviya took to his official Twitter account and wrote that India has 'expanded its vaccine basket'.

Read more about Opportunity for potential vaccine entrants in India shrinking: Analysts on Business Standard. The government has recently set the maximum price that private hospitals can charge for the three Covid-19 vaccines currently available in India

By the end of 2021, India might have access to 6 COVID-19 vaccines, all in the pipeline and being locally developed.

India News: NEW DELHI: Developed by Texas Children’s Hospital Center for Vaccine Development (TCHCVD) at Baylor College of Medicine, the Corbevax Covid-19 vaccine.

The problem isn't that the Indian government is backing novel technologies even before they have been proven. It's that the Indian drug regulator is dysfunctional.

(Image source from: english.jagran.com) Biological Es Corbevax could be the cheapest vaccine in India:- Biological Es Corbevax could be the cheapest vaccination for coronavirus in India and it is priced at Rs 500 for both the doses. Biological Es Corbevax is yet to get its approval for emergency use in the country. Corbevax is an RBD protein sub-unit vaccine and will be available for public usage in the country in the next few months as per the report from the Union Health Ministry. Some of th...

Know all about Biological-E’s Corbevax that could be India's cheapest COVID-19 vaccine - As many as 30 crore doses of Corbevax are expected to be rolled out between August and December.

Second made-in-India COVID vaccine: Centre seals deal with Biological-E for 30 crore doses Times Now | Embed The health ministry has finalised arrangements with Hyderabad-based vaccine manufacturer Biological-E to book 30 crore COVID-19 vaccine doses, set to be manufactured and stockpiled from August to December this year. As per a health ministry statement on Thursday, an advance payment of Rs 1,500 crore will be made to Biological-E from the Centre. This is the second made-in-India vaccine a...